OF
PCRX icon

Outfitter Financial’s Pacira BioSciences PCRX Stock Holding History

Outfitter Financial’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,065
Closed -$246K – 81
2024
Q4 		$246K Sell
13,065
-5,720
-30% -$100K 0.2% 80
2024
Q3 		$283K Sell
18,785
-1,405
-7% -$24K 0.23% 76
2024
Q2 		$578K Buy
20,190
+1,095
+6% +$31.2K 0.48% 65
2024
Q1 		$558K Buy
19,095
+65
+0.3% +$2K 0.46% 65
2023
Q4 		$642K Sell
19,030
-13,275
-41% -$388K 0.56% 62
2023
Q3 		$991K Buy
32,305
+110
+0.3% +$3.96K 0.93% 44
2023
Q2 		$1.29M Buy
32,195
+795
+3% +$32.9K 1.15% 40
2023
Q1 		$1.28M Buy
31,400
+5,540
+21% +$220K 1.15% 40
2022
Q4 		$998K Buy
25,860
+440
+2% +$21.4K 0.91% 48
2022
Q3 		$1.35M Buy
25,420
+855
+3% +$47.5K 1.32% 29
2022
Q2 		$1.43M Sell
24,565
-125
-0.5% -$8.19K 1.3% 29
2022
Q1 		$1.88M Hold
24,690
– – 1.44% 26
2021
Q4 		$1.49M Buy
24,690
+1,000
+4% +$55.1K 1.09% 36
2021
Q3 		$1.33M Buy
23,690
+240
+1% +$13.8K 1.04% 40
2021
Q2 		$1.42M Sell
23,450
-445
-2% -$28.2K 1.09% 38
2021
Q1 		$1.68M Sell
23,895
-1,345
-5% -$96.1K 1.38% 26
2020
Q4 		$1.51M Buy
+25,240
New +$1.48M 1.46% 26

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Outfitter Financial's PCRX Position: Q1 2025 in Review

Outfitter Financial sold out of Pacira BioSciences (PCRX) in Q1 2025, closing a stake of 13,065 shares — an estimated $246K sold.

Outfitter Financial first reported a position in PCRX in Q4 2020 and held it in 17 quarters. The position peaked at $1.88M in Q1 2022. 235 funds tracked by Wall St. Rank hold PCRX as of Q1 2025.

  • Outfitter Financial reported no remaining Pacira BioSciences position as of Q1 2025 after selling out during the quarter.
  • Outfitter Financial sold 13,065 Pacira BioSciences shares in Q1 2025, an estimated $246K.
  • Outfitter Financial first reported a position in Pacira BioSciences in Q4 2020 and held it in 17 quarters.
  • Outfitter Financial's Pacira BioSciences position peaked at $1.88M in Q1 2022.
  • 235 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2025.

Based on Outfitter Financial's 13F filing for Q1 2025, filed 5 May 2025.